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Summary 
Trypanosoma brucei survives in the mammalian blood- 
stream by regularly changing its variant surface glyco- 
protein (VSG) coat. The active VSG gene is located in 
a telomeric expression site, and coat switching occurs 
either by replacing the transcribed VSG gene or by 
changing the expression site that is active. To deter- 
mine whether VSG expression site control requires 
promoter-specific sequences, we replaced the active 
VSG expression site promoter in bloodstream-form T. 
brucei with a ribosomal DNA (rDNA) promoter. These 
transformants were fully infective in laboratory ani- 
mals, and the rDNA promoter, which is normally con- 
stitutively active, was efficiently inactivated and reac- 
tivated in the context of the VSG gene expression site. 
As there is no sequence similarity between the VSG 
expression site promoter and the rDNA promoter, VSG 
expression site control does not involve sequences 
specific to the VSG expression site promoter. We con- 
clude that an epigenetic mechanism, such as telomeric 
silencing, is involved in VSG expression site control 
in bloodstream-form T. brucei. 
Introduction 
African sleeping sickness in humans is caused by Trypa- 
nosoma brucei, a unicellular parasite that multiplies in the 
blood of mammals. T. brucei avoids immune destruction 
by repeatedly changing its variant surface glycoprotein 
(VSG) coat. Each trypanosome has hundreds of VSG 
genes. To be expressed, these genes have to move to a 
discrete telomeric location known as an expression site, 
which contains multiple expression site-associated genes 
(ESAGs) besides the telomeric VSG gene (Kooter et al., 
1987; Johnson et al., 1987; Pays et al., 198913). Although 
there are up to 20 VSG expression sites (Cullyet al., 1985) 
only one is transcribed at a time. VSG switching can in- 
volve DNA rearrangement events whereby a silent VSG 
gene replaces the active VSG gene in the expression site. 
Alternatively, trypanosomes can change the VSG gene 
expressed by switching between VSG expression sites, 
an in situ switch (reviewed by Van der Ploeg, 1991; Pays 
et al., 1994). 
Acentralquestion in antigenicvariation is howthe blood- 
stream-form trypanosome can silence all VSG expression 
sites except one. VSG expression sites are highly similar 
to each other, and no DNA sequence changes or predict- 
able DNA rearrangements have been detected upon tran- 
scriptional inactivation of an active expression site (Zomer- 
dijk et al., 1990). The only distinguishing feature is an 
unusual DNA modification present only in inactive VSG 
expression sites (Bernards et al., 1984b; Pays et al., 1984; 
Gommers-Ampt et al., 1993). 
Inactivation of VSG expression sites also occurs in in- 
sect-form T. brucei. In this life cyclestage, VSG expression 
sites are down-regulated partly at the level of transcription 
initiation (Rudenko et al., 1994) and partly by transcription 
attenuation (Pays et al., 1989a; Rudenko et al., 1994). 
Down-regulation in insect-form T. brucei appears to have 
a promoter sequence-specific component. When the en- 
dogenous expression site promoter is replaced by a ribo- 
somal DNA (rDNA) promoter, this results in an escape 
from down-regulation (Rudenko et al., 1994). This type of 
experiment is feasible in trypanosomes, as rDNA promot- 
ers are capable of directing high levels of transcription of 
marker protein-coding genes in these organisms (Rudenko 
et al., 1991; Zomerdijk et al., 1991a). 
Here we address the control mechanisms used by 
bloodstream-form trypanosomes to silence all VSG ex- 
pression sites rigorously except for the active ones. We 
have remodeled the active VSG expression site by delet- 
ing the endogenous promoter and replacing it with the 
rDNA promoter, which is normally constitutively active. 
These transformants were fully infective in laboratory ani- 
mals and were capable of silencing and reactivating the 
heterologous rDNA promoter as efficiently as the endoge- 
nous VSG expression site promoter. 
Results 
An rDNA Promoter Can Direct Transcription 
of a VSG Expression Site 
In transient transfection studies, we have previously 
shown that the promoter of the 221 VSG expression site 
in our 427 stock of T. brucei is very small. A fragment 
extending from -60 bp to +77 bp relative to the start of 
transcription was sufficient for maximal promoter activity 
(Zomerdijk et al., 1991c). An extensive deletion analysis 
extending 2.5 kb upstream (Zomerdijk et al., 1991c) and 
1.4 kb downstream of the promoter (our unpublished data) 
did not give any indication for additional enhancer or si- 
lencer elements. Analogous results using the AnTat 1.3A 
expression site promoter were obtained by Jeffries et al. 
(1991). 
To study the 221 VSG expression site promoter in its 
native chromosomal surroundings, we have marked it by 
targeting a hygromycin resistance gene directly down- 
stream of the promoter (enES2; see Figure 1A). We have 
also replaced a 315 bp fragment encompassing the endog- 
enous promoter with either an rDNA promoter (Rf2X) or a 
plasmid-derived 221 VSG expression site promoter (ES2x) 
directing expression of the selectable marker (Figure 1 B). 
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Figure 1. Remodeling the Active 221 Expression Site Promoter Re- 
gion in Bloodstream-Form T. brucei 
(A) Integration of the hygromycin resistance gene behind the endoge- 
nous 221 expression site promoter. The map indicates the promoter 
region of the 221 expression site, with the promoter indicated by an 
open flag. Upstream of the promoter are imperfect 50 bp repeats, 
indicated by a vertically striped box. Downstream of the promoter is 
the first gene in the expression site (ESAG-i), shown as a closed box. 
The transfection construct is indicated underneath (e&%2). After inte- 
gration, the hygromycin resistance gene (hatched box) with RNA pro- 
cessing signals (open boxes) is inserted into the Sphl site 272 bp 
downstream of transcription initiation. Restriction enzymes: Spl, Spel; 
Hpl, Hpal; SI, Sall; Stl, Stul; D, Dral; H, Hindlll; B, BamHI. Note that 
only relevant restriction enzyme sites have been indicated. 
(B) Exchange of the 221 expression site promoter for a construct- 
derived 221 expression site promoter (fS2X) or rDNA promoter (RPPX) 
directing expression of the hygromycin resistance gene. The broken 
lines indicate how the constructs integrate into the 221 expression 
site promoter region. The box marked with a closed flag indicates the 
rDNA promoter fragment. After integration, these constructs resulted 
in insertion of a hygromycin gene at the Sall site 82 bp downstream 
of transcription initiation. 
Each of these constructs gave rise to hygromycin-resistant 
trypanosomes with a frequency of about 1 O-6 to 1 O-7, the 
transformation efficiency also observed for constructs tar- 
geted to other areas of the genome (Carruthers et al., 
1993; our unpublished data). We have verified for each 
transformant that the construct had been inserted by ho- 
mologous recombination into the 221 VSG expression site 
in chromosome 15 (data not shown) (for nomenclature see 
Gottesdiener et al., 1990). 
Each of these VSG expression site transformants ex- 
pressed the single copy hygromycin resistance gene at a 
high level, as shown for two constructs in the RNA blots 
in Figure 2. Levels of expression of the hygromycin gene 
were comparable, irrespective of whether the rDNA pro- 
moter (RP2X-7 in lane 5 of Figure 2) or the expression site 
promoter (enES2-7 in lane 2) directed transcription of the 
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Figure 2. RNA Analysis of the enES2 and RP2X T.brucei Trans- 
formants and the Switched Trypanosomes Derived from Them 
Lane 1 shows RNA from wild-type 221a trypanosomes; lane 2, RNA 
from transformant enESP-I; and lanes3 and 4, RNAfrom twoswitched 
trypanosome clones derived from enES2-7 (respectively, enES2-7R7 
and enES2-7R2). Lane 5 shows RNA from transformant RP2X, and 
lanes 6 and 7, RNA from two switched clones derived from RPPX 
(respectively, RPZX-7R7 and RP2X-1R2). The blot was hybridized with 
a hygromycin probe (hygro) before being rehybridized with a 221 VSG 
gene-specific probe (221) and a tubulin probe (tub). Total RNA (20 ng) 
was loaded per lane. 
active VSG expression site. Interestingly, the rDNA pro- 
moter, which normally directs expression of a 10 kb rDNA 
transcription unit (White et al., 1986; Johnson et al., 1987), 
was fully capable of directing transcription of the entire 
60 kb 221 VSG expression site transcription unit (Kooter 
et al., 1987; Johnson et al., 1987). Expression of the 221 
VSG gene, the most telomeric gene of the VSG expression 
site, was not affected by the promoter replacements. The 
ES2X transformant had levels of expression comparable 
to enES2-7 (data not shown). All transformants had the 
same growth rate as wild-type trypanosomes, and they 
were all fully infective in laboratory mice or rats. 
Transformants with Remodeled VSG Expression 
Sites Can Undergo Expression Site Switching 
To see whether the restructured VSG expression sites 
could be switched off, we used the transformants to infect 
mice preimmunized against the 221 VSG coat. In these 
mice, all trypanosomes carrying the 221 coat were rapidly 
and consistently killed, whereas those that had switched 
to the production of another coat survived. For each 
transgenic line, we obtained clones that had switched us- 
ing any of the major mechanisms of switching. The total 
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switching frequency of both wild-type and transformant 
trypanosomes was between 1O-6 and lo-‘, as had been 
found previously for the 427 T. brucei strain (Lamont et 
al., 1986). For details on how trypanosomes that had re- 
lapsed via an in situ switch were selected, see Experimen- 
tal Procedures. 
RNA blot analysis was performed on the enESP-7 T. 
brucei transformant and on two relapsed daughter clones 
that had both undergone in situ switches (see Figure 2). 
As expected, there is no hygromycin mRNA in wild-type 
T. brucei (Figure 2, lane l), while the level of hygromycin 
mRNA from the trypanosome with the marked expression 
site (enfSE-7) is high (lane 2). In contrast, the relapsed 
daughter trypanosomes that had both undergone in situ 
switches, enESP-7R7 (Figure 2, lane 3) and enES2-7R2 
(lane 4), shut down transcription of the hygromycin resis- 
tance gene and of the 221 VSG gene present in the same 
expression site transcription unit. Analogous results were 
obtained with trypanosomes derived from the ES2X-7 
transformant that had relapsed in the same fashion (data 
not shown). 
These results are in striking contrast with those obtained 
with the same constructs in insect-form T. brucei, where 
VSG gene expression sites are only partially down- 
regulated at the level of transcription initiation (Rudenko 
et al., 1994). We conclude that inactive VSG expression 
sites in bloodstream-form T. brucei are down-regulated 
exclusively at the level of transcription initiation. This is 
consistent with the finding that nearly all cDNAs corre- 
sponding to VSG expression site promoter region tran- 
scripts of bloodstream-form T. brucei are identical in se- 
quence to the active VSG expression site (Rudenko et al., 
1994). 
An rDNA Promoter Directing Transcription of the 
VSG Expression Site Can Be Silenced 
To test whether the switching off of VSG expression sites 
is dependent on the DNA sequence of the promoter area, 
we repeated the relapse experiments with trypanosomes 
in which the expression site promoter had been replaced 
by an rDNA promoter. This is a stringent test, as ribosomal 
promoters are normally constitutively active in dividing 
cells. 
Figure 2 shows that the transformant with an active VSG 
expression site driven by an rDNA promoter (RP2X-7) was 
fully capable of switching via an in situ switch. RNA analy- 
sis of the RP2X-7 transformant shows a high level of hygro- 
mycin mRNA (Figure 2, lane 5). In relapsed clones derived 
from this transformant that had undergone an in situ 
switch, RP2X-7R7 (Figure 2, lane 6) and RP2X-7R2 (lane 
7), the level of expression of the hygromycin resistance 
gene was drastically down-regulated. As expected, tubulin 
gene expression was unaffected, and 221 VSG gene ex- 
pression was only detectable in the original nonrelapsed 
trypanosomes. Quantitation showed that the level of ex- 
pression from an rDNA promoter-driven hygromycin resis- 
tance gene in an inactivated 221 VSG expression site was 
more than 300-fold lower than from the same promoter in 
an active 221 VSG expression site. We conclude that the 
rDNA promoter can be regulated by the same epigenetic 
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Figure 3. PFG Analysis of the RPW Transformant and the Switched 
Clone f?P2X-7R7 in Which the rDNA Promoter-Driven VSG Expression 
Site Has Been Silenced 
Lanes 1 show RP2X-7 and lanes 2, RP2X-7R7. The first panel (Eth) 
is an ethidium stain of the gel in which the chromosomes have been 
separated into bands. The panel marked hy shows hybridization of 
the blot to a hygromycin-specific probe, and panel marked 221 to a 
221 VSG gene-specific probe. The panel marked V02 was hybridized 
with a probe specific for the V02 VSG gene that was expressed in the 
switched RP2X-7R7 trypanosomes. 
mechanism involved in VSG expression site down- 
regulation, even though the rDNA and the VSG expression 
site promoter have no significant sequence homology 
(Janz and Clayton, 1994; Pays et al., 1994). Although we 
did not detect hygromycin mRNA in long exposures of 
Northern blots using total RNA from the relapsed enES2 
or RP2X transformants, the IC, of trypanosomes with a 
silenced rDNA promoter (20 pg of hygromycin per milliliter) 
was higher than for trypanosomes with a silenced expres- 
sion site promoter (1 pg of hygromycin per milliliter). The 
degree of silencing was therefore somewhat tighter for the 
VSG expression site promoter. In comparison, trypano- 
somes with a hygromycin gene in an active VSG expres- 
sion site grew well in more than 300 pg of hygromycin per 
milliliter. 
In most of the switched trypanosomes described here 
(enES2-7R7, RP2X-7R7, and RP2X-7R2), the in situ switch 
led to the activation of a VSG expression site in chromo- 
somal band 2 containing a VSG gene that we call VO2 
(see Experimental Procedures). To check whether DNA 
rearrangements had occurred during the VSG switch, we 
performed pulsed field gel (PFG) analysis with RP2X-7 
and the relapsed RP2X-7R7 transformant (Figure 3). As 
expected, the hygromycin gene, the 221 VSG gene, and 
the new VSG gene expressed (V02) did not change chro- 
mosomal location in the relapsed daughter trypanosome 
RP2X-7R7 (lanes 2 in Figure 3) compared with the trans- 
formant RP2X-7 (lanes 1). Under these PFG conditions, 
a fraction of large molecular weight DNA remains trapped 
in the slot, but this was similar in all samples. The lack of 
detectable DNA rearrangements in these relapsed try- 
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screening switched trypanosomes for an in situ 
switch (transcriptional inactivation of the 221 
RP2 RPZR RPZRR WT VSG expression site), we isolated the trypano- 
some clone RPW-7R7 (RP2R). RPPR was used 
to select for trypanosomes that had reactivated 
1 2 3 4 5 6 7 the 221 expression site using hygromycin 
(RP2RR). 
(B) Western blot analysis showing expression 
of the 221 VSG in trypanosomes that have 
switched back to expression of the rDNA pro- 
moter-driven 221 VSG expression site. Try- 
panosome lysates were size fractionated on an 
- 
8% SDS-polyacrylamide gel that was blotted, 
and the blot was incubated with a polyclonal 
anti-221 VSG antibody. Lanes 1 and 2 show 
lysate from transformant Rf2X-7 (respectively, 
from lo5 or IO4 trypanosomes). Lanes 3 and 4 
have lysates from the relapsed variant RPPX- 
7R7 (respectively, from lo5 or IO4 trypano- 
Figure 4. Reactivation of the 221 Expression 
Site Using Drug Selection Pressure 
RPZRR (A) Schematic showing inactivation and reacti- 
vation of VSG gene expression sites. The large 
boxes represent trypanosomes, which contain 
schematic VSG gene expression sites. The 
- 
-------, 
RPZX-7 transformant (RP2) has transcription of 
its 221 expression site (broken line) directed 
by an rDNA promoter, indicated with a closed 
flag. The hatched box indicates the hygromycin 
resistance gene; the closed box, the 221 VSG 
gene: and the stippled box (labeled VSG X), 
a VSG gene expressed from a different VSG 
expression site promoter (open flag). After 
somes). Lanes 5 and 6 show lysate from a clone that has been selected for reexpression of the 221 VSG expression site using hygromycin 
(RP2X.IRIRI) (respectively, from lo5 or lo4 trypanosomes). Lane 7 has lysate from lo5 wild-type (WT) 221a trypanosomes. 
panosomes is therefore fully compatible with an in situ 
switch. Similar PFG results were obtained with the other 
Transcriptionally inactive VSG expression sites of T. 
relapsed transformants (data not shown). 
brucei are invariably characterized by an unusual nucleo- 
tide present near the telomeres, which leads to partial 
restriction enzyme digestion by Pvull and Pstl (Bernards 
et al., 1984b; Pays et al., 1984). A similar modification was 
found in the rDNA promoter-driven VSG expression sites 
that had been silenced (data not shown), showing that 
telomere modification is unaltered when the VSG expres- 
sion site promoter is replaced by a foreign promoter. 
Reactivation of a Silenced rDNA Promoter 
It is one thing to silence a ribosomal promoter in a VSG 
expression site, but can it also be reactivated? To test this, 
we took trypanosome lines with a silenced 221 expression 
site that had been derived from a single switched trypano- 
some and selected them on 100 pg of hygromycin per 
milliliter. This procedure kills all trypanosomes that do not 
transcribe the hygromycin resistance gene at a very high 
rate, and it selects for trypanosomes that have switched 
the 221 expression site back on again (Figure 4A). This in 
vitroselection procedureworkedwell. Both theeMS7R7 
and enES2-7R2 relapsed trypanosomes, as well as the 
RP2X-1Rl and RP2X-lR2trypanosomes, switched at high 
frequencies (1 x 10m5) back to expression of the 221 ex- 
pression site. Switching frequencies of the enES2 and 
RPW transformants were comparable, indicating that the 
silenced rDNA promoter could be reactivated as effec- 
tively as the silenced endogenous VSG expression site 
Using Western blot analysis with an anti-221 VSG poly- 
clonal antiserum, we checked whether the 221 VSG gene 
was expressed in these “back-switchers”, as shown in Fig- 
promoter. 
ure 48 for the rDNA promoter transformants. The original 
transformant with the 221 expression site driven by the 
rDNA promoter (RP2X-7) produced 221 VSG (Figure 48, 
lanes 1 and 2) similar to wild-type 221a T. brucei (Figure 
4B, lane 7). After relapse (RP2X-7R7 in lanes 3 and 4 of 
Figure 4B), expression of the 221 VSG disappeared. In- 
stead, there was weak cross-reactivity with a larger protein 
that is presumably the new VSG expressed (V02). Al- 
though the polyclonal anti-221 antiserum was produced 
against purified 221 VSG, different VSG molecules resem- 
ble each other at the C-termini (Rice-Ficht et al., 1981) 
so this cross-reactivity is not unexpected. Trypanosomes 
that had “relapsed” to expression of the 221 expression 
site (Figure 48, lanes 5 and 6) did not appear to be double 
expressors, as reverse transcription polymerase chain re- 
action (RT-PCR) analysis of the VSG gene expressed 
showed only evidence for expression of the 221 VSG gene. 
The frequency of reactivation of the 221 expression site 
using the silenced drug resistance gene was high in our 
relapsed trypanosome clones (1 x 10m5) compared with 
the total switching frequency of 1 x 1Om6 to 1 x lo-‘. We 
think that VSG expression sites may be switching on more 
frequently than previously thought, but that the presence 
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of a second limiting step (for example, the rate of inactiva- 
tion of the old VSG expression site) results in a low total 
switching frequency. We are doing experiments to ad- 
dress this. 
Discussion 
Gottschling et al. (1990) described telomeric silencing in 
Saccharomyces cerevisiae whereby promoters located 
near telomeres are repressed in an unstable fashion. They 
proposed that African trypanosomes, such as T. brucei, 
may use this phenomenon to switch off telomeric VSG 
expression sites. In this paper we have tested several as- 
pects of that proposal. 
First, we have checked whether VSG gene expression 
sites are controlled at transcription initiation, as predicted 
by the silencing model, or at transcription elongation. We 
find by RNA blot analysis that a marker gene inserted 
either 82 bp or 272 bp downstream of a silent expression 
site promoter is not detectably transcribed. Although this 
does not exclude the possibility that the RNA polymerase 
drops off directly after starting, our data are most simply 
explained by control at initiation rather than at elongation. 
This is the result expected for telomeric silencing, but it 
is nevertheless remarkable because control of VSG ex- 
pression sites in the insect-form T. brucei is fundamentally 
different. In this life cycle stage, expression sites are in 
part shut off by transcription attenuation occurring within 
0.5-l kb downstream of the promoter (Rudenko et al., 
1994). 
Second, we have tested whether transcriptional inacti- 
vation of VSG expression sites requires the precise se- 
quence of the VSG expression site promoter. One would 
expect this to be the case for the type of silencers involved 
in tissue-specific and stage-specific repression (Johnson, 
1995), but not for telomeric silencing. Interestingly, the 
rDNA promoter-driven expression site was silenced as effi- 
ciently as one directed by the normal VSG expression site 
promoter. Silencing was also fully reversible, as it was 
possible to reactivate these expression sites with a high 
frequency (at least 1 in lo5 trypanosomes), similar to fre- 
quencies of reactivation of a silenced VSG expression site 
promoter. 
How different is the VSG expression site driven by the 
rDNA promoter from its natural counterpart? The rDNA 
promoter does not share obvious sequence homology with 
the VSG expression site promoter in sequences critical 
to control (Janz and Clayton, 1994; Pays et al., 1994), and 
the VSG expression site promoter is smaller, indicating a 
different promoter architecture (Zomerdijk et al., 1991~). 
It is likely, however, that both the rDNA and the VSG ex- 
pression site promoter as well as the procyclic acidic repet- 
itive protein (PARP) promoter are all recognized by RNA 
polymerase I, as all three promoters direct expression of 
transcription units with similar levels of insensitivity to 
a-amanitin and sarkosyl (Rudenko et al., 1992). It has been 
demonstrated that the rDNA and PARP promoters of T. 
brucei contain dissimilar sequence elements that are func- 
tionally interchangeable(Janz and Clayton, 1994). Despite 
the lack of significant sequence homology between the 
rDNA and the VSG expression site promoter, it is not in- 
conceivable that critical elements could be interchanged. 
In our promoter replacement experiments, however, we 
replaced the entire region known to be required for maxi- 
mal expression site promoter activity in insect-form try- 
panosomes (Zomerdijk et al., 1991c) and in bloodstream- 
form trypanosomes (our unpublished data). This shows 
that VSG expression site promoter-specific sequence ele- 
ments are not critical for VSG expression site control in 
bloodstream-form trypanosomes. 
It is remarkable that the rDNA promoter can be efficiently 
regulated within the genomic context of the VSG expres- 
sion site, as the regulation of rDNA promoters that has 
been previously described has been the consequence of 
reduced growth or stalling within the cell cycle (Schnapp 
et al., 1990; Cavanaugh et al., 1995). In our case, asingle 
rDNA promoter in the inactive VSG expression site is 
down-regulated, while the rDNA promoters in the rDNA 
remain unaffected. 
The chromosomal position effect known as telomeric 
silencing provides a powerful, relatively sequenceinde- 
pendent epigenetic mechanism for the stochastic revers- 
ible inactivation of transcription units (reviewed by Palla- 
dino and Gasser, 1994). Telomeric silencing was originally 
described in S. cerevisiae, where it was shown that pro- 
moters located near telomeres are repressed in an unsta- 
ble fashion (Gottschling et al., 1990). Silent domains are 
assembled contiguously from the telomere end and are 
maintained by a complex set of chromatin proteins. The 
stability of the repressed state decreases with increasing 
distance between promoter and telomere and with in- 
creasing promoter strength (Renauld et al., 1993). 
Our results are compatible with a specialized telomere 
position effect operating on VSG expression sites. First, 
all known VSG expression sites in T. brucei are located 
at telomeres. These sites are of two types: the bloodstream 
sites studied here and the metacyclic sites switched on 
in the salivary gland of the tsetse fly and active during the 
first few days after the trypanosome enters its mammalian 
host (Lenardo et al., 1986). Metacyclic expression site pro- 
moters have no sequences in common with bloodstream 
expression site promoters, but they are also turned on 
in a mutually exclusive fashion (Alarcon et al., 1994). A 
telomere position effect operating in a promotersequence- 
nonspecific fashion provides an appealing model to ex- 
plain the analogous regulation of two types of telomeric 
VSG expression site transcription units that have no strik- 
ing sequence similarities. Second, as we show here, re- 
pression of VSG expression sites is not specific for the 
sequence of expression site promoters. The VSG expres- 
sion site and rDNA promoters, which are completely dis- 
similar in sequence, are nearly equally well repressed. 
This promoter nonspecificity is similar to what has been 
found for telomeric silencing in yeast, where four different 
RNA polymerase II transcription units were reversibly re- 
pressed in the genomic location of the telomere (Gottsch- 
ling et al., 1990). Third, activation and inactivation of VSG 
expression sites appear to occur by a stochastic process 
and are independent of signals from outside. 
Although our results are compatible with a telomere po- 
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sition effect controlling VSG expression sites, telomeric 
silencing in trypanosomes is clearly different in detail from 
silencing in yeast. First, VSG expression site promoters 
are 45-60 kb upstream of the chromosome end. Telomere 
position effect in T. brucei would need to extend farther 
than has been observed in S. cerevisiae, where transcrip- 
tion units 20 kb away from the chromosome end escaped 
repression (Gottschling et al., 1990; Renauld et al., 1993). 
Second, a telomere position effect in T. brucei would have 
to be more stable than what has been described in yeast 
(1 in 10-l per division [Gottschling et al., 19901). The rate 
of in situ switching between VSG expression sites in our 
strain of T. brucei is orders of magnitude lower. Third, a 
VSG expression site regulating telomere position effect 
would need to operate on RNA polymerase I transcription 
units. Telomere position effect in yeast has only been dem- 
onstrated with RNA polymerase II transcription units. 
We find these modifications not incompatible with a 
modified telomere position effect silencing VSG expres- 
sion sites in T. brucei. This would make T. brucei unique 
in its use of the semistable nature of the telomere position 
effect to vary the expression of a large family of telomeric 
transcription units. 
Experimental Procedures 
Trypanosomes 
The experiments were all performed with bloodstream-form T. brucei 
427VSG 221a (MiTat 1.2a) (Cross, 1975; Bernards et al., 1984a). The 
221 VSG gene in this variant is a single copy and is expressed in an 
expression site on chromosome 15 (Zomerdijk et al., 1990; Gottes- 
diener et al., 1990). Prior to all experiments, the 221a variant was 
cloned (Carruthers and Cross, 1992). Culturing was in laboratory ro- 
dents or in vitro in HMI-9 medium (Hirumi and Hirumi, 1989) or on 
agarose plates (Carruthers and Cross, 1992). 
Stable Transformation 
DNA Constructs 
Constructs enES2, ESZX, and RPW are analogous to enES, ESXI, 
and RfX7 of Fiudenko et al. (1994), except that the targeting flanks 
were derived from the promoter area of the 221 a expression site (Zom- 
erdijk et al., 1990) instead of the dominant expression site (DES). A 
hygromycin resistance gene with tubulin RNA processing signals was 
used in all constructs (see Rudenko et al., 1994). The enES2 construct 
has target fragments from the 221 expression site promoter area: 5’ 
is a 190 bp Sall-Sphl and 3’ is a 685 bp Sphl-Stul fragment. The 
ESZX construct has a 2.8 kb Sail 5’target fragment including the ex- 
pression site promoter and extending into the 50 bp repeat array and 
a 875 bp Sall-Stul 3’target fragment (Zomerdijk et al., 1990). In the 
RPZX construct, the expression site promoter was deleted (315 bp 
Hpal-Sal1 fragment) and replaced with the rDNA promoter on a 518 
bp Alul fragment as described by Rudenko et al. (1994). Upon integra- 
tion of the enfS2 construct, the hygromycin gene was inserted into 
the Sphl site 272 bp downstream of transcription initiation, and the 
ES2X and RP2X constructs were integrated behind the Sail site 82 bp 
downstream of initiation (Zomerdijk et al., 1991 b; Pays et al., 1994). 
Transfection 
T. brucei was electroporated essentially according to Carruthers et 
al. (1993) and selected on agarose plates with 2 vg of hygromycin B 
per milliliter. 
T. brucei Relapse Experiments 
In Vivo Relapses 
T. brucei that were to be relapsed were injected into mice that had 
been immunized with variant 221 a and treated with cyclophosphamide 
(0.3 mglg) 24 hr before challenge. Transformants (3 x 106) were in- 
jected into each mouse. T. brucei relapses were cloned (Carruthers 
and Cross, 1992) and checked by PCR for the single-copy 221a gene. 
Loss of the gene would indicate a switch involving a duplicative gene 
conversion event into the 221 expression site. Presence of the 221a 
gene could indicate an in situ switch or a telomere exchange. PFG 
analysis was used to differentiate between these two posslbllmes. For 
the enES2 transformant, 2 out of 5 relapsed trypanosome clones ana- 
lyzed had undergone an in situ switch. For the RP2X transformant, 7 
out of 15 relapsed T. brucei clones had undergone an in situ switch. 
Using RT-PCR (Rudenko et al., 1994), we amplified VSG cDNA 
from the relapsed T. brucei. cDNA identity was established using fin- 
gerprinting with restriction enzymes and using sequence analysis. The 
clones enESB7R7, RP2X-7R7, and RPZX-7R2 express the VO2 VSG 
gene, and enES2-7R2 expresses the 7.8 VSG gene (Michels et al., 
1984). 
In Vitro Relapses 
Relapsed T. brucei were switched back to the 221 expression site 
using selection with 20 pg of hygromycin B (for enES2 transformants) 
and 100 pg of hygromycin B (for RPX2 transformants) per milliliter. 
Colonies arising on the plates were expanded in the absence of drug. 
DNA, RNA, and Protein Analyses 
Genomic DNA 
PFG electrophoresis was according to Zomerdijk et al. (1990), with a 
switching time of 260 s. Southern blots were according to Sambrook 
et al. (1989) and were washed to an end stringency of 65°C in 0.1 x 
ssc. 
DNA Probes 
The hygromycin probe is a 680 bp fragment of the hygromycin resis- 
tance gene between the Ncol site and the stop codon (Gritz and Davies, 
1983). The 221 VSG gene-specific probe is the 590 bp Pstl fragment 
of TcV227.5 (Bernards et al., 1984a). The tubulin probe is the 760 bp 
Hindlll-EcoRI fragment from pTbc@T-1 (Thomashow et al., 1983). 
RNA Blots 
RNA was isolated with the guanidinium thiocyanate-cesium chloride 
procedure, electrophoresed in 1% formaldehyde gels, and blotted ac- 
cording to Sambrook et al. (1989). Quantitation was with a Fuji 
BASZOOO Phosphorlmager. 
Protein Blots 
T. brucei protein preparations were made according to Ligtenberg et 
al. (1994). After blotting, thefilterwas incubated with arabbit polyclonal 
antibody directed against purified 221 VSG protein (obtained from 
G. A. M. Cross). lmmunodetection was with enhanced chemilumines- 
cence (Amersham). These procedures were all according to Ligten- 
berg et al. (1994). 
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